Aina Muceniece
Aina Muceniece | |
---|---|
Born |
Katlakalns, Riga district, Latvia | March 23, 1924
Died |
February 14, 2010 Jelgava, Latvia |
Ethnicity | Latvian |
Alma mater | Latvian State University, Faculty of Medicine |
Occupation | Scientist, inventor of RIGVIR medicine |
Aina Muceniece (March 23, 1924 – February 14, 2010), Dr.habil.med., Latvian scientist, immunologist, Emeritus Scientist, inventor of anticancer drug RIGVIR. Honorary member of the Latvian Association of Oncologists, received Cross of Recognition for meritorious service to the Latvian Republic.
Life and work
Aina Muceniece was born in Katlakalns, Latvia, graduated Vilis Olavs school in Riga and worked as a nurse during the Second World War in Yaroslav, USSR. After the war, she studied medicine at Latvian State University, where she received doctor's degree.[1]
Started her scientific career in A. Kirhenshtein Institute of Microbiology (Latvian Academy of Sciences), first as senior laboratory assistant, after as senior research associate. In 1960s, she discovered the phenomenon of viruses able to destroy cancerous cells and started researching this phenomenon. In 1965, Virotherapy Laboratory was founded in A. Kirhenshtein Institute of Microbiology, A.Muceniece became head of the laboratory and led it until 1989. During this period, various trials of RIGVIR were held in the laboratory.[2] Also worked at Pauls Stradiņš Hospital and National Oncology Center as immunology consultant.
Publications
- A.Muceniece, N.Pakalninsh. Viral neuroinfections Coxsackie and ECHO. Riga, 1964. Publisher Latvian Academy of Sciences. 129 p. (Russian lang.)
- A.Muceniece. Oncotropism of viruses and cancer virotherapy problem. Riga, 1972, Science, 443, p. (Russian lang.)
- A.Muceniece, A.Ferdats. Virology (Manual). Riga, 1985, Zvaigzne. 200 pp. (Latvian lang.)
- Translated scientific book: Ivan Pavlov. Collection of articles. Latvian State Publishing House. Riga, 1952, 440 p. (Russian lang.)
- Oncotropism of viruses. Riga, Zinatne, 1969, 219 p. (Russian lang.)
- Viruses in cancer therapy. Experimental studies. Riga. Zinatne, 1978, 204 p. (Russian lang.)
- Immunological aspects of viral oncotropism. Riga. Zinatne, 1979, 120 p. (Russian lang.)
- Heterogenization of tumours. Riga. Zinatne, 1980, 159 p. (Russian lang.)
- Tumour immunology. Riga. Zinatne, 1982. 207 p. (Russian lang.)
- Non-specific stimulants of tumour immunotherapy. Riga. Zinatne, 1985, 223 pages. (Russian lang.)
- Modulation of anti-cancer immunity in the postoperative period. Riga. Zinatne, 1988, 142 pp. (Russian lang.)
- A.Muceniece, R.Bruvere, D.Venskus, G.Feldmane. Methodological indications for the use of biological medicines Rigvir and Larifan in oncology and for the prevention of secondary immunodeficiency. Publisher: Society of Aina Muceniece to develop cancer immunotherapy, Jelgava, 2006.
- A.Muceniece, D.Venskus. How to evaluate the immune system. Melanoma model. Publisher: Society of Aina Muceniece to develop cancer immunotherapy, Riga, 2008. (Latvian lang.)
References
|